Cargando…
Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2
Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly ind...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879983/ https://www.ncbi.nlm.nih.gov/pubmed/33585253 http://dx.doi.org/10.3389/fonc.2020.627463 |
_version_ | 1783650622733549568 |
---|---|
author | Gross-Cohen, Miriam Feld, Sari Arvatz, Gil Ilan, Neta Vlodavsky, Israel |
author_facet | Gross-Cohen, Miriam Feld, Sari Arvatz, Gil Ilan, Neta Vlodavsky, Israel |
author_sort | Gross-Cohen, Miriam |
collection | PubMed |
description | Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly indicates that Hpa2 is not a pseudogene but rather a gene coding for an important protein. Hpa2 lacks the heparan sulfate (HS)-degrading activity typical of heparanase, yet exhibits high affinity to HS, affinity that is 10-fold higher than that of heparanase. The consequences of this high-affinity interaction of Hpa2 with plasma membrane HSPG has not been explored yet. Here, we used highly purified Hpa2 protein to examine this aspect. We provide evidence that cells adhere to and spread on dishes coated with Hpa2. We also show that cell migration is attenuated markedly by exogenous addition of Hpa2 to primary and transformed cells, a function that agrees with the anti-cancer properties of Hpa2. Interestingly, we found that exogenous addition of Hpa2 also disrupts the morphology of cell colonies, resulting in cell scattering. This implies that under certain conditions and experimental settings, Hpa2 may exhibit pro-tumorigenic properties. We further developed a panel of anti-Hpa2 monoclonal antibodies (mAb) and show that these properties of Hpa2 are prevented by some of the newly-developed mAb, thus providing new molecular tools to better appreciate the significance of Hpa2 in health and disease. |
format | Online Article Text |
id | pubmed-7879983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78799832021-02-13 Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 Gross-Cohen, Miriam Feld, Sari Arvatz, Gil Ilan, Neta Vlodavsky, Israel Front Oncol Oncology Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly indicates that Hpa2 is not a pseudogene but rather a gene coding for an important protein. Hpa2 lacks the heparan sulfate (HS)-degrading activity typical of heparanase, yet exhibits high affinity to HS, affinity that is 10-fold higher than that of heparanase. The consequences of this high-affinity interaction of Hpa2 with plasma membrane HSPG has not been explored yet. Here, we used highly purified Hpa2 protein to examine this aspect. We provide evidence that cells adhere to and spread on dishes coated with Hpa2. We also show that cell migration is attenuated markedly by exogenous addition of Hpa2 to primary and transformed cells, a function that agrees with the anti-cancer properties of Hpa2. Interestingly, we found that exogenous addition of Hpa2 also disrupts the morphology of cell colonies, resulting in cell scattering. This implies that under certain conditions and experimental settings, Hpa2 may exhibit pro-tumorigenic properties. We further developed a panel of anti-Hpa2 monoclonal antibodies (mAb) and show that these properties of Hpa2 are prevented by some of the newly-developed mAb, thus providing new molecular tools to better appreciate the significance of Hpa2 in health and disease. Frontiers Media S.A. 2021-01-29 /pmc/articles/PMC7879983/ /pubmed/33585253 http://dx.doi.org/10.3389/fonc.2020.627463 Text en Copyright © 2021 Gross-Cohen, Feld, Arvatz, Ilan and Vlodavsky http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Gross-Cohen, Miriam Feld, Sari Arvatz, Gil Ilan, Neta Vlodavsky, Israel Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title | Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title_full | Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title_fullStr | Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title_full_unstemmed | Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title_short | Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 |
title_sort | elucidating the consequences of heparan sulfate binding by heparanase 2 |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879983/ https://www.ncbi.nlm.nih.gov/pubmed/33585253 http://dx.doi.org/10.3389/fonc.2020.627463 |
work_keys_str_mv | AT grosscohenmiriam elucidatingtheconsequencesofheparansulfatebindingbyheparanase2 AT feldsari elucidatingtheconsequencesofheparansulfatebindingbyheparanase2 AT arvatzgil elucidatingtheconsequencesofheparansulfatebindingbyheparanase2 AT ilanneta elucidatingtheconsequencesofheparansulfatebindingbyheparanase2 AT vlodavskyisrael elucidatingtheconsequencesofheparansulfatebindingbyheparanase2 |